Sofinnova Venture Partners X, L.P.
SEC CIK 1680200 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | 10% | 3.40M | $5.00M | — | 2 | 2021-07-02 | 2021-07-02 |
Most active insiders at JBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Balta Elizabeth | See Remarks | — | — |
| 2 | Frohlich Tom | CEO, Dir | — | — |
| 3 | King Andrew James | See Remarks | — | — |
| 4 | Dahms Bradford D. | CFO | — | — |
| 5 | Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Sofinnova Venture Partners X, L.P. made no open-market trades at JBIO in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Sofinnova Venture Partners X, L.P. | 10% | C - Cnv Deriv | — | +3.40M | 3.40M | New | — |
| D | 2021-07-06 | 2021-07-02 | JBIO | Jade Biosciences, Inc. | Sofinnova Venture Partners X, L.P. | 10% | P - Purchase | $14.00 | +357.1K | 3.76M | +10% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations